2018. Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S47. DOI:https://doi.org/10.25251/skin.2.supp.47.